Clinical features reported in telephone enquiries related to suspected methoxetamine exposure
| Feature group | Reported terms | Number of cases | % of total (95% CI) |
|---|---|---|---|
| Stimulant | Tachycardia, hypertension, mydriasis, palpitation, increased sweating | 17 | 36 (24 to 50) |
| Acute mental health disturbance | Agitation, confusion, euphoria, aggression, hallucination, paranoia, hysteria, manic reaction, psychosis | 20 | 43 (30 to 57) |
| Dissociative | Catatonia, dystonia, hypertonia, tetany | 5 | 11 (5 to 23) |
| Cerebellar | Nystagmus, tremor | 3 | 6 (2 to 17) |
| Reduced consciousness | Reduced conscious level, stupor, somnolence, coma | 8 | 17 (9 to 30) |
| Seizures | Seizures | 1 | 2.1 (0 to 11) |